$UNITREE #UnitreeJumpsNearly12%

Why did an Apple-related move cause a sudden surge in this robotics stock?

Shares of Unitree climbed over 11% during morning trading in November, pushing the price above 700 yuan—with the rally extending to as much as 15% throughout the day—reflecting a broader sector-wide recovery for "physical AI" stocks in China. Sources have confirmed that the catalyst for this surge was a new autonomous control system for humanoid robots, developed by Apple’s research team and released as open-source; the system was tested on a Unitree robotic platform, achieving task success rates of up to 91%. It is also noted that the company has experienced significant volatility since its IPO in August, alongside a decline in profits in its latest financial report and a price-to-earnings (P/E) ratio exceeding 500.

What changed following this "Apple bombshell"?

At first glance, an unexpected name lies behind this 11% jump: Apple. Last week, the company’s research team announced a new autonomous control system for humanoid robots on an academic platform, making the entire codebase open-source and accessible to everyone. Most striking is that the system was integrated directly into a small, humanoid robot from Unitree; the robot is capable of applying skills learned in simulations to entirely new environments—rooms it has never encountered before—and has achieved an average success rate of 91% across hundreds of distinct tasks in real-world testing.

The chain of cause and effect here is critical: this move—stretching from Apple’s core business of smartphones into robotics research—serves as the clearest signal yet that tech giants are making a serious entry into the field of physical AI. The market’s logic here is as follows: if one of the companies at the forefront of developing "brains" for artificial intelligence chooses Unitree to provide the "body," then this manufacturer could well become a foundational infrastructure provider for the future. During the morning session, robotics stocks across China surged in unison—some even hitting their daily upper limits—with Unitree serving as the flagship of this rally.

It must be stated candidly, however, that a single research paper will not change a company’s revenue overnight. This is not a product launch; it is the pricing of hope. What should one watch for? Apple’s roadmap for this system, along with similar moves by other tech giants, will be key; the actual arrival of products from these heavyweights would create a far more sustainable foundation than a rally triggered merely by a research paper.

What has this stock—which has seen such a meteoric, almost frantic rise since August—actually gone through?

Unitree’s story reads like a novel. In mid-August, the company went public on a Chinese exchange dedicated to tech stars; the demand for its IPO reached 8,000 times the target—a level of mass enthusiasm that shattered records. On its first day of trading, the share price skyrocketed, pushing the company’s valuation above $50 billion in a single morning. Its founder became one of the youngest individuals to join the ranks of China’s wealthiest people.

Then, the narrative shifted. A broad pullback hit AI-related stocks in China; the tech index shed hundreds of billions of dollars in value over the following months, and Unitree’s share price fell to half of its peak. Even regulators grew concerned, effectively freezing new IPOs for humanoid robotics companies. Why such a sharp decline? Because the initial public offering (IPO) price had already priced in a decade of flawless performance for the company; when the first earnings report revealed the reality, investors headed for the exits in a hurry.

The current phase represents the third act of these ups and downs. In early November, following a double-notch upgrade by a major investment bank, the stock surged nearly 65% in a single week—even though the company itself warned of valuation risks. In other words, today’s jump isn’t happening in a vacuum; it follows a 50–60% rally over the past month. What should one watch for? The stock remains far below its peak, and a return to the price levels seen on its first day of trading would suggest that the market—once again—is leaning on fantasy rather than fundamentals.

What do the two sides of the balance sheet reveal?

To balance the excitement of the rally, one must examine the balance sheet. In the last quarter, the company’s revenue grew by approximately 70% year-over-year—a respectable growth rate. For the first nine months, revenue growth stood at 56%, marking a clear deceleration from the 300% explosion seen in 2025. In short, while growth remains robust, it is losing momentum—falling short of the market’s vision of a "robot empire" that doubles in size every single year.

The real turning point lies in profitability: net profit for the last quarter fell by more than 17% compared to the same period last year, coming in at roughly half of what analysts had expected. Meanwhile, the gross profit margin has slipped from approximately 60% to 54% over the course of the year; while the official reports have yet to pinpoint the exact cause, rising competition and cost pressures are likely factors. The robotics giant is currently trading at a multiple of roughly 570 times earnings and over 100 times its annualized revenue—figures that essentially admit the current valuation is driven more by faith than by the actual balance sheet.

On the other hand, the bullish case cannot be ignored: the company produced over 31,000 robots in 2025, shipments in the first half of this year have already surpassed the total for all of last year, and 40% of its revenue is now generated outside of China. The demand is real, and the product is real. What should one watch for? Whether the contraction in profit margins halts in the coming quarter, and whether revenue growth dips below 50%. The narrative of a "breakthrough point" hinges entirely on these two metrics.

On what is the founder’s claim—that 2027 will be a breakthrough year—actually based? The valuation of this company today is driven less by its balance sheet and more by a timeline-based claim. Its 36-year-old founder asserts that a major leap in "physical AI" will occur within one to three years—with 2027 likely serving as the industry’s inflection point—and that by 2028, humanoid robots could be capable of performing 80% of all tasks. While these may simply be the visionary remarks of a CEO, the market is pricing them as if they were a prophecy.

Drawing a parallel from historical precedent, the founder advocates for an architecture that offloads cognitive functions to AI running in the cloud, while retaining only low-latency, cerebellum-like motor functions within the robot itself. If this architecture proves sound, robots would automatically benefit from the rapidly evolving capabilities of large-scale AI models; indeed, Apple’s open-source move this week was interpreted by many as a validation of this very thesis. The market’s logic is clear: if software capabilities explode, the manufacturers of the physical "bodies" will unlock immense value.

Yet, in the same discussion, the founder acknowledges that robots still face significant shortcomings—specifically in perceiving their surroundings during delicate assembly tasks and in learning from repeated failures. In other words, the 2027 timeline is not a guarantee, but a target. What should one watch for? Concrete milestones that would support this 2027 claim: commercial deployment agreements in actual factories, robot orders from major corporations, and the results of industrial pilot programs.

Where does the geopolitical shadow leave this company?

An unseen element of the story—one that will ultimately determine the company’s long-term valuation—is geopolitics. In July, the United States added Chinese-made humanoid and quadrupedal robots to a list that effectively blocks the import of new models; while Unitree’s existing six models remain authorized, the door has closed for any new ones. Furthermore, it is understood that the White House issued a new national security directive regarding imported robots in early November. With the U.S. accounting for 13% of the company’s revenue last year, this segment of the market is rapidly shutting down.

The impact of this bottleneck is twofold: it stifles the company’s global growth ambitions while simultaneously strengthening its position within China, where it operates as a state-backed champion, leveraging economies of scale to stay ahead of more than 200 domestic rivals. Meanwhile, the company has been involved in some notable promotional events; last week, a quadrupedal robot from one of its units won the speed category in a climbing competition held on one of China’s sacred mountains—a feat that state media broadcast for days. While China may be grappling with American giants in the race for software, it continues to assert its strength in hardware.

To clarify this asymmetry: the battle for "robot brains" is playing out among major software firms, whereas on the "physical" side, Chinese manufacturers are pulling ahead thanks to their advantages in cost and production volume. The extent to which these two spheres converge will be the primary factor shaping the trajectory of robotics-related stocks in the coming year. Key indicators to watch include whether additional models are added to the U.S. restricted list and how the company’s revenue share from outside China evolves; should the export channel continue to narrow, intensifying competition within the domestic market could place further pressure on profitability.

The story of Unitree offers one of the most instructive capital market lessons of the year: a stock does not necessarily have to be a great investment just because it represents a great company. The products are real, shipments are on the rise, and the founder is a visionary; yet, the valuation multiples are priced based on a "leap of faith"—a belief that the reality of actual profitability will arrive decades down the line. For stocks like these, the source of both gains and losses is not the balance sheet, but rather the strengthening or weakening of the underlying narrative. Keep in mind that this morning’s 11% surge was driven not by an earnings report, but by a single research paper.

The second lesson concerns one’s relationship with volatility: an IPO oversubscribed by 8,000 times, a price that doubled on the first day, a subsequent 50% decline, a 65% rally in a single week, and today’s jump. Amidst these swings, the investor who claims "this time it’s different" is, once again, the one pricing the narrative at its absolute peak. When a company itself issues a warning regarding valuation risk, it is perhaps the most honest statement management can make; after all, management tends to issue such warnings during periods of euphoria, not during panic selling. Paying attention to a management team that issues a warning in the midst of such excitement is just as important as reading a research paper.

The third lesson is about mastering the calendar and the catalysts. There are three distinct engines driving the price of this stock: narrative milestones—such as the founder’s projections for 2027—moves into robotics by major tech firms, and the realities of the balance sheet. An investor who can distinguish which news affects which engine—without conflating the three—will be better equipped to gauge the sustainability of any market reaction to a headline. Robots might perform most tasks by 2028, but for now, you should emulate the role of those who act with discipline in this market.

This content is for informational purposes only and does not constitute investment advice.

#Gate股票畅聊季 #GateStockTalkSeason #ShareWeekly
#USSTOCK